ANA by Immunoblot

Double-stranded DNA (dsDNA) is the primary genetic material in most living organisms, consisting of two complementary nucleotide strands coiled into a double helix. In clinical and scientific contexts, it frequently refers to diagnostic anti-dsDNA antibody tests used to detect and monitor autoimmune diseases like Systemic Lupus Erythematosus (SLE).

A nucleosome is the fundamental structural unit of DNA packaging in eukaryotic cells. It consists of a segment of negatively charged DNA wrapped nearly two times around an octamer of positively charged histone proteins, resembling thread on a spool.

Histones are highly alkaline, positively charged proteins found in the nuclei of eukaryotic cells. They act as structural spools around which negatively charged DNA wraps, organizing the genome into compact structures called chromatin and playing a vital role in regulating gene expression.

A PCNA (Proliferating Cell Nuclear Antigen) test measures the levels of the PCNA protein or its corresponding autoantibodies in the blood or tissue. It primarily serves as a marker for active cell division, rapid tumor growth, and DNA repair, as well as an indicator for specific autoimmune diseases.

An SS-A/Ro60 test is a blood test that detects specific autoantibodies (immune proteins) called anti-Ro60. These antibodies often mistakenly target the body's own tissues, particularly RNA-protein complexes inside cells.

Clinical Significance

A positive SS-A/Ro60 result typically indicates to a rheumatologist that further clinical investigation is needed. Specific clinical associations include:

• Connective Tissue Diseases: Helps evaluate symptoms like severe dry eyes and dry mouth (Sjögren's) or butterfly rashes and joint pain (Lupus).
• Pregnancy and Neonatal Risks: SS-A/Ro antibodies can cross the placenta. In pregnant women with a history of autoimmune disease, a positive test indicates a higher risk for neonatal lupus and congenital heart block in the newborn.
• Organ Involvement: In lupus patients, anti-Ro positivity is often associated with skin involvement (cutaneous lupus) and kidney inflammation (lupus nephritis).

The CENP-B test is a blood test that detects antibodies targeting Centromere Protein B (CENP-B), a major autoantigen. It is primarily ordered to help diagnose autoimmune connective tissue diseases, most notably limited scleroderma (CREST syndrome), and is also useful in investigating conditions like Primary Biliary Cholangitis (PBC).

The Scl-70 test (Anti-Topoisomerase I) is a blood test that detects specific autoantibodies associated with systemic sclerosis (scleroderma). A positive result suggests a higher likelihood of the diffuse cutaneous form of the disease, which carries a greater risk for skin thickening and internal organ complications like lung fibrosis.

The AMA-M2 (Anti-Mitochondrial Antibody, type M2) test is a specialized blood test used to detect specific autoantibodies that mistakenly attack the body's own mitochondria. It is the most specific and reliable biomarker utilized by doctors to help diagnose Primary Biliary Cholangitis (PBC), a chronic autoimmune disease that causes damage to the bile ducts in the liver.

The Jo-1 antibody test is a blood test that detects specific autoantibodies associated with autoimmune diseases like polymyositis and dermatomyositis. Finding these antibodies helps your doctor diagnose inflammatory muscle diseases and evaluate related conditions like interstitial lung disease.

Anti-Mi-2 antibodies are myositis-specific autoantibodies strongly associated with dermatomyositis, an inflammatory muscle and skin disease. They target nuclear proteins involved in gene regulation. Detecting this antibody is highly specific for dermatomyositis, indicating a generally better response to treatment and a lower risk of cancer or lung disease.

Anti-Ku antibodies are rare autoantibodies that target the Ku protein complex, which is essential for repairing damaged DNA. A positive test usually points to connective tissue diseases (CTDs), particularly overlap syndromes combining polymyositis (muscle inflammation) and systemic sclerosis (scleroderma).

An SmD1 antibody (anti-SmD1) is a highly specific autoantibody targeting the SmD1 protein, which is a core component of the spliceosome in human cell nuclei. It is primarily used as a highly specific diagnostic biomarker for Systemic Lupus Erythematosus (SLE).